The Oral Microbiome: The Biology Behind the Oral–Systemic Connection
The oral microbiome — over 700 species in dynamic balance — is the biological engine of the oral-systemic connection. Part 2 explains the three key pathogens, two systemic pathways, and why scaling and root planing is mechanistically systemic disease management.
Research
Oral–Systemic Health Series — Part 2 of 4. Part 1 introduced the three pathways through which oral disease reaches distant organs. This post goes into the biology — the specific organisms driving systemic harm and what the latest microbiome science means clinically. --- Over 700 microbial species colonise the human oral cavity. Most are commensal — they cause no harm and actively compete against pathogens for resources and space.
In health, this community exists in a stable equilibrium called eubiosis . Disease begins when that equilibrium collapses. Oral Microbiome Dysbiosis: The Ecological Tipping Point The transition from health to disease in the oral cavity is ecological, not simply microbiological. Periodontitis is not caused by the arrival of a single pathogen — it results from a shift in the balance of the entire community.
Dysbiosis is triggered by smoking, high-sugar diet, xerostomia, antibiotic overuse, uncontrolled systemic disease, and inadequate mechanical plaque disruption. This distinction matters systemically. It is the dysbiotic state — not isolated bacteraemia events — that sustains the chronic inflammatory burden reaching distant organs. A single bacterial species cannot explain the oral-systemic connection.
The disrupted community can. Three Pathogens Clinicians Must Know Porphyromonas gingivalis — The Keystone Pathogen P. gingivalis is present in very small quantities in the healthy oral cavity. Its influence is disproportionate to its abundance. It is classified as a keystone pathogen because it manipulates the entire microbial community to create a dysbiotic environment that supports its own survival — while suppressing the host immune response.
Its systemic reach is unmatched among oral organisms: - Detected in atherosclerotic plaques , where it triggers endothelial dysfunction and promotes thrombus formation - Detected in Alzheimer's brain tissue — Dominy et al. ( Science Advances , 2019) identified its DNA and toxic proteases (gingipains) in the hippocampus and cerebral cortex at significantly higher levels than in age-matched controls - Produces peptidylarginine deiminase (PPAD) — the only known bacterial enzyme capable of citrullinating host proteins, generating anti-citrullinated protein antibodies (ACPAs), the hallmark autoantibody of rheumatoid arthritis, often years before joint symptoms appear Fusobacterium nucleatum — The Bridge Organism F.
nucleatum occupies a structural role in biofilm architecture, bridging early and late colonisers. In dysbiotic conditions it becomes invasive: - Consistently detected in colorectal cancer tissue — enriched in tumour compared to adjacent normal mucosa ( Genome Research , 2012; multiple subsequent confirmations) - Promotes tumour progression through FadA adhesin-mediated invasion of intestinal epithelial cells and suppression of anti-tumour immunity via the Wnt/β-catenin pathway - Identified in the gut microbiome of patients with inflammatory bowel disease , suggesting oral seeding of the gut via the oral-gut axis Streptococcus mutans (Cnm-positive strains) — The Caries Pathogen with Vascular Consequences Not all S.
mutans strains carry equivalent risk. Those expressing Cnm — collagen-binding protein of S. mutans — adhere to vascular collagen and cardiac valve tissue following bacteraemia. Nakano et al. ( Stroke , 2013) demonstrated significantly higher rates of cerebral microbleeds in patients harbouring Cnm-positive strains. Untreated caries is not a localised problem in patients with cerebrovascular or cardiac risk.
This is one reason the evidence on dental antibiotic prescribing in Saudi Arabia deserves attention alongside the microbiome data — antibiotic overuse disrupts the very commensal communities that keep these pathogens in check. The Two Systemic Pathways in Detail Bacteraemia and Haematogenous Spread Brushing, flossing, scaling, chewing, and even gingival manipulation introduce oral bacteria transiently into the bloodstream.
In the immunocompetent patient with intact vasculature, these events are cleared within minutes. In patients with damaged heart valves , prosthetic implants , uncontrolled diabetes , or established atherosclerosis , the same organisms find receptive surfaces. P. gingivalis and S. mutans bind to collagen and fibronectin in vascular and cardiac tissue. The resulting inflammatory cascade — local and systemic — is the mechanism underlying infective endocarditis, atheromatous plaque destabilisation, and cerebrovascular events.
The Oral-Gut Axis Each day, a healthy adult swallows approximately 1.5 litres of saliva carrying roughly 100 million bacteria per millilitre. In eubiosis, this load is largely composed of commensals destroyed by gastric acid or passing harmlessly through the gut. In dysbiosis, oral pathogens survive in sufficient quantities to alter gut microbiome composition. A 2019 study in the Journal of Oral Microbiology identified oral-origin P.
gingivalis and F. nucleatum within the gut microbiome of patients with inflammatory bowel disease. Altered mucosal immunity, increased intestinal permeability, and systemic inflammatory signalling are the downstream consequences — an underappreciated pathway through which oral disease contributes to gut and systemic pathology. What This Means for How You Treat Scaling and root planing is not simply removing calculus.
It disrupts a dysbiotic community, reduces the pathogenic load entering the bloodstream and gut, and lowers the systemic inflammatory signal. That reframing matters — for how you explain treatment to patients, and for how you justify treatment intensity to yourself. Chlorhexidine and antiseptic rinses used indiscriminately disrupt commensal communities and may accelerate the return of dysbiosis. Precision mechanical debridement targeting the subgingival niche remains the most evidence-supported intervention.
The biology explains why chlorhexidine's effect on the oral microbiome deserves more nuanced clinical thinking than rout